Capstan TMVR System for Mitral Regurgitation
What You Need to Know Before You Apply
What is the purpose of this trial?
This early feasibility study is evaluating the safety and performance of the Capstan Compass Robotic System™ for transcatheter mitral valve replacement in patients with symptomatic, moderate-to-severe or severe mitral regurgitation who are unsuitable for surgical repair or transcatheter edge-to-edge repair.
Are You a Good Fit for This Trial?
This trial is for people with moderate-to-severe or severe mitral regurgitation (a leaky heart valve) who have symptoms and cannot have standard surgical repair or other less invasive procedures.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Capstan Compass Robotic System for Transcatheter Mitral Valve Replacement
Trial Overview
The study is testing the Capstan Compass Robotic System, a new robotic device used to replace the mitral valve through a minimally invasive procedure. The main goal is to see if it works safely in these patients.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants will undergo transcatheter mitral valve replacement
Find a Clinic Near You
Who Is Running the Clinical Trial?
Capstan Medical
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.